Spero Therapeutics, Inc. · NASDAQ:SPRO
Zack Debra received 162,311 Spero Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 3, 2026 · Filed Aug 6, 2026
On Aug 3, 2026, Zack Debra (Chief Medical Officer) received 162,311 Spero Therapeutics, Inc. shares as an award under a trading plan, leaving 162,311 shares. Filed Aug 6, 2026 (Form 4).
- Awarded
- 162,311 shares
- Holding after
- 162,311 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Award | 162,311 | 162,311 | Direct |